Abzena PLC Stock Price, News & Analysis (LON:ABZA)

GBX 32.25 0.00 (0.00 %)
(As of 11/20/2017 12:11 PM ET)
Previous CloseGBX 32.25
Today's RangeGBX 33 - GBX 0.32
52-Week RangeGBX 27.73 - GBX 66
Volume43,914 shs
Average Volume152,608 shs
Market Capitalization£67.5 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Abzena PLC (LON:ABZA)

Abzena PLC logoAbzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups. It offers immunogenicity assessment, which includes EpiScreen, iTope and T Cell Epitope Database (TCED); antibody drug conjugates, which includes ThioBridge linkers; antibody, which includes Composite Human Antibodies and Composite Proteins; optimization of pharmacokinetics, which includes TheraPEG, HiPEG conjugates PEG to poly-histidine motifs and CyPEG, and PolyPEG; cell line development, which includes Composite Human Antibody; process development, Good manufacturing practices (GMP) manufacturing, and small molecules. The Company's Abzena inside includes Composite Human Antibodies and ThioBridge Antibody Drug Conjugates (ADCs).


Industry, Sector and Symbol:
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Sector: Biotechnology & Medical Research - NEC
  • Symbol: LON:ABZA
  • CUSIP: N/A
  • Web: www.abzena.com
Profitability:
  • Trailing EPS: GBX (0.07)
  • Net Margins: -52.49%
  • Return on Equity: -26.96%
  • Return on Assets: -21.90%
Misc:
  • Outstanding Shares: 213,820,000
 

Frequently Asked Questions for Abzena PLC (LON:ABZA)

What is Abzena PLC's stock symbol?

Abzena PLC trades on the London Stock Exchange (LON) under the ticker symbol "ABZA."

Where is Abzena PLC's stock going? Where will Abzena PLC's stock price be in 2017?

2 analysts have issued 1-year target prices for Abzena PLC's stock. Their forecasts range from GBX 70 to GBX 80. On average, they anticipate Abzena PLC's share price to reach GBX 75 in the next twelve months. View Analyst Ratings for Abzena PLC.

Who are some of Abzena PLC's key competitors?

How do I buy Abzena PLC stock?

Shares of Abzena PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Abzena PLC's stock price today?

One share of Abzena PLC stock can currently be purchased for approximately GBX 32.25.

How big of a company is Abzena PLC?

Abzena PLC has a market capitalization of £67.5 million.

How can I contact Abzena PLC?

Abzena PLC's mailing address is Babraham Hall, Babraham Research, CAMBRIDGE, CB22 3AT, United Kingdom. The company can be reached via phone at +44-1223-903498.


MarketBeat Community Rating for Abzena PLC (LON ABZA)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  72 (Vote Underperform)
Total Votes:  168
MarketBeat's community ratings are surveys of what our community members think about Abzena PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Abzena PLC (LON:ABZA)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 75

Consensus Price Target History for Abzena PLC (LON:ABZA)

Price Target History for Abzena PLC (LON:ABZA)

Analysts' Ratings History for Abzena PLC (LON:ABZA)

Show:
DateFirmActionRatingPrice TargetDetails
9/22/2017FinnCapLower Price TargetBuyGBX 80 -> GBX 70View Rating Details
9/14/2017Numis Securities LtdReiterated RatingBuyGBX 80View Rating Details
4/26/2017N+1 SingerReiterated RatingCorporateView Rating Details
(Data available from 11/20/2015 forward)

Earnings

Earnings History for Abzena PLC (LON:ABZA)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Abzena PLC (LON:ABZA)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Abzena PLC (LON:ABZA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Abzena PLC (LON ABZA)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Abzena PLC (LON ABZA)

Source:
DateHeadline
Novel Antibodies against a Ground-Breaking New Target for the Treatment of Cardiovascular Fibrosis Developed by Enleofen Bio, with Support from Abzena, Featured in ‘Nature ...Novel Antibodies against a Ground-Breaking New Target for the Treatment of Cardiovascular Fibrosis Developed by Enleofen Bio, with Support from Abzena, Featured in ‘Nature ...
www.businesswire.com - November 14 at 8:41 PM
Novel Antibodies against a Ground-Breaking New Target for the Treatment of Cardiovascular Fibrosis Developed by ... - Business Wire (press release)Novel Antibodies against a Ground-Breaking New Target for the Treatment of Cardiovascular Fibrosis Developed by ... - Business Wire (press release)
www.businesswire.com - November 14 at 3:39 PM
Novel Antibodies against a Ground-Breaking New Target for the Treatment of Cardiovascular Fibrosis Developed by Enleofen Bio, with Support from Abzena, Featured in ‘Nature’ ArticleNovel Antibodies against a Ground-Breaking New Target for the Treatment of Cardiovascular Fibrosis Developed by Enleofen Bio, with Support from Abzena, Featured in ‘Nature’ Article
finance.yahoo.com - November 14 at 3:39 PM
Abzena and UGA Biopharma Partner to Develop a Cell Line Expressing a Biosimilar Therapeutic for Multiple Sclerosis - Business Wire (press release)Abzena and UGA Biopharma Partner to Develop a Cell Line Expressing a Biosimilar Therapeutic for Multiple Sclerosis - Business Wire (press release)
www.businesswire.com - October 20 at 8:35 PM
Abzena and UGA Biopharma Partner to Develop a Cell Line Expressing a Biosimilar Therapeutic for Multiple SclerosisAbzena and UGA Biopharma Partner to Develop a Cell Line Expressing a Biosimilar Therapeutic for Multiple Sclerosis
finance.yahoo.com - October 19 at 3:31 PM
What Are The Drivers Of Abzena plc’s (AIM:ABZA) Risks?What Are The Drivers Of Abzena plc’s (AIM:ABZA) Risks?
finance.yahoo.com - October 6 at 3:44 PM
Abzena PLC (ABZA) PT Lowered to GBX 70Abzena PLC (ABZA) PT Lowered to GBX 70
www.americanbankingnews.com - September 23 at 12:52 AM
Abzena PLCs (ABZA) Under Review Rating Reaffirmed at FinnCapAbzena PLC's (ABZA) Under Review Rating Reaffirmed at FinnCap
www.americanbankingnews.com - September 17 at 12:58 AM
Abzena PLCs (ABZA) Buy Rating Reaffirmed at Numis Securities LtdAbzena PLC's (ABZA) Buy Rating Reaffirmed at Numis Securities Ltd
www.americanbankingnews.com - September 16 at 11:02 PM
Abzena PLC (ABZA) Stock Rating Reaffirmed by FinnCapAbzena PLC (ABZA) Stock Rating Reaffirmed by FinnCap
www.americanbankingnews.com - August 28 at 5:02 PM
Abzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen AntibodiesAbzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies
finance.yahoo.com - July 18 at 3:36 PM
Abzena and OBI Pharma Sign ThioBridge™ Licence Agreement - Business Wire (press release)Abzena and OBI Pharma Sign ThioBridge™ Licence Agreement - Business Wire (press release)
www.businesswire.com - July 13 at 8:47 PM
Abzena and OBI Pharma Sign ThioBridge™ Licence AgreementAbzena and OBI Pharma Sign ThioBridge™ Licence Agreement
finance.yahoo.com - July 11 at 4:25 PM
Annual Report and Accounts - London South East (registration) (blog)Annual Report and Accounts - London South East (registration) (blog)
www.lse.co.uk - June 20 at 1:25 AM
Blocklisting update - London South East (registration) (blog)Blocklisting update - London South East (registration) (blog)
www.lse.co.uk - January 11 at 1:30 AM
Half Year 2017 Abzena PLC Earnings Release - Time Not SuppliedHalf Year 2017 Abzena PLC Earnings Release - Time Not Supplied
biz.yahoo.com - November 30 at 11:05 AM

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Abzena PLC (LON ABZA) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.